Impact of age and co-morbidity on surgical resection rate and survival in patients with oesophageal and gastric cancer

British Journal of Surgery

Volumn 99, Issue 12, 2012, Pages 1693-1700

  Koppert, L B ^a   Lemmens, V E P P ^a,b   Coebergh, J W W ^a,b   Steyerberg, E W ^a   Wijnhoven, B P L ^a   Tilanus, H W ^a   Janssen Heijnen, M L G ^c  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b Eindhoven Cancer Registry   (Netherlands)

^c VIECURI MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOCARCINOMA; ADULT; AGE; AGED; ARTICLE; CARDIA; ESOPHAGUS TUMOR; FEMALE; HUMAN; MALE; MIDDLE AGED; MORTALITY; PROSPECTIVE STUDY; SQUAMOUS CELL CARCINOMA; STOMACH TUMOR; SURVIVAL RATE; TREATMENT OUTCOME;

ADENOCARCINOMA; ADULT; AGE FACTORS; AGED; CARCINOMA, SQUAMOUS CELL; CARDIA; ESOPHAGEAL NEOPLASMS; FEMALE; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; STOMACH NEOPLASMS; SURVIVAL RATE; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84868671388     PISSN: 00071323     EISSN: 13652168     Source Type: Journal    
DOI: 10.1002/bjs.8952     Document Type: Article

References (28)

1. Dikken JL, Lemmens VE, Wouters MW, Wijnhoven BP, Siersema PD, Nieuwenhuijzen GA, et al., Increased incidence and survival for oesophageal cancer but not for gastric cardia cancer in the Netherlands. Eur J Cancer 2012; 48: 1624-1632.
2. Enzinger PC, Mayer RJ,. Esophageal cancer. N Engl J Med 2003; 349: 2241-2252.
3. Dickson JL, Cunningham D,. Systemic treatment of gastric cancer. Eur J Gastroenterol Hepatol 2004; 16: 255-263.
4. Wijnhoven BP, Siersema PD, Hop WC, van Dekken H, Tilanus HW,. Adenocarcinomas of the distal oesophagus and gastric cardia are one clinical entity. Rotterdam Oesophageal Tumour Study Group. Br J Surg 1999; 86: 529-535.
5. Dassen AE, Lemmens VE, van de Poll-Franse LV, Creemers GJ, Brenninkmeijer SJ, Lips DJ, et al., Trends in incidence, treatment and survival of gastric adenocarcinoma between 1990 and 2007: a population-based study in the Netherlands. Eur J Cancer 2010; 46: 1101-1110.
6. Janssen-Heijnen ML, Houterman S, Lemmens VE, Louwman MW, Maas HA, Coebergh JW,. Prognostic impact of increasing age and co-morbidity in cancer patients: a population-based approach. Crit Rev Oncol Hematol 2005; 55: 231-240.
7. Charlson ME, Pompei P, Ales KL, MacKenzie CR,. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987; 40: 373-383.
8. Koppert LB, Janssen-Heijnen ML, Louwman MW, Lemmens VE, Wijnhoven BP, Tilanus HW, et al., Comparison of comorbidity prevalence in oesophageal and gastric carcinoma patients: a population-based study. Eur J Gastroenterol Hepatol 2004; 16: 681-688.
9. Trivers KF, De Roos AJ, Gammon MD, Vaughan TL, Risch HA, Olshan AF, et al., Demographic and lifestyle predictors of survival in patients with esophageal or gastric cancers. Clin Gastroenterol Hepatol 2005; 3: 225-230.
10. Paulson EC, Ra J, Armstrong K, Wirtalla C, Spitz F, Kelz RR,. Underuse of esophagectomy as treatment for resectable esophageal cancer. Arch Surg 2008; 143: 1198-1203.
11. Kinugasa S, Tachibana M, Yoshimura H, Dhar DK, Shibakita M, Ohno S, et al., Esophageal resection in elderly esophageal carcinoma patients: improvement in postoperative complications. Ann Thorac Surg 2001; 71: 414-418.
12. Poon RT, Law SY, Chu KM, Branicki FJ, Wong J,. Esophagectomy for carcinoma of the esophagus in the elderly: results of current surgical management. Ann Surg 1998; 227: 357-364.
13. Sabel MS, Smith JL, Nava HR, Mollen K, Douglass HO, Gibbs JF,. Esophageal resection for carcinoma in patients older than 70 years. Ann Surg Oncol 2002; 9: 210-214.
14. Pultrum BB, Bosch DJ, Nijsten MW, Rodgers MG, Groen H, Slaets JP, et al., Extended esophagectomy in elderly patients with esophageal cancer: minor effect of age alone in determining the postoperative course and survival. Ann Surg Oncol 2010; 17: 1572-1780.
15. Schwarz RE, Karpeh MS, Brennan MF,. Factors predicting hospitalization after operative treatment for gastric carcinoma in patients older than 70 years. J Am Coll Surg 1997; 184: 9-15.
16. Bartels H, Stein HJ, Siewert Jr,. Risk analysis in esophageal surgery. Recent Results Cancer Res 2000; 155: 89-96.
17. Stein HJ, Brücher BL, Sendler A, Siewert Jr,. Esophageal cancer: patient evaluation and pre-treatment staging. Surg Oncol 2001; 10: 103-111.
18. Schröder W, Bollschweiler E, Kossow C, Hölscher AH,. Preoperative risk analysis-reliable predictor of postoperative outcome after transthoracic esophagectomy? Langenbecks Arch Surg 2006; 391: 455-460.
19. Steyerberg EW, Neville BA, Koppert LB, Lemmens VE, Tilanus HW, Coebergh JW, et al., Surgical mortality in patients with esophageal cancer: development and validation of a simple risk score. J Clin Oncol 2006; 24: 4277-4284.
20. Murray P, Whiting P, Hutchinson SP, Ackroyd R, Stoddard CJ, Billings C,. Preoperative shuttle walking testing and outcome after oesophagogastrectomy. Br J Anaesth 2007; 99: 809-811.
21. Cronin-Fenton DP, Sharp L, Carsin AE, Comber H,. Patterns of care and effects on mortality for cancers of the oesophagus and gastric cardia: a population-based study. Eur J Cancer 2007; 43: 565-575.
22. Siewert JR, Ott K,. Are squamous and adenocarcinomas of the esophagus the same disease? Semin Radiat Oncol 2007; 17: 38-44.
23. Lerut T, De Leyn P, Coosemans W, Van Raemdonck D, Scheys I, LeSaffre E,. Surgical strategies in esophageal carcinoma with emphasis on radical lymphadenectomy. Ann Surg 1992; 216: 583-590.
24. Lieberman MD, Shriver CD, Bleckner S, Burt M,. Carcinoma of the esophagus. Prognostic significance of histologic type. J Thorac Cardiovasc Surg 1995; 109: 130-138.
25. Siewert JR, Stein HJ, Feith M, Bruecher BL, Bartels H, Fink U,. Histologic tumor type is an independent prognostic parameter in esophageal cancer: lessons from more than 1000 consecutive resections at a single center in the Western world. Ann Surg 2001; 234: 360-367.
26. Orringer MB,. Age does not preclude an esophagectomy ∥ If only it were that simple. Ann Surg Oncol 2010; 17: 1487-1489.
27. Piccirillo JF, Tierney RM, Costas I, Grove L, Spitznagel EL Jr,. Prognostic importance of comorbidity in a hospital-based cancer registry. JAMA 2004; 291: 2441-2447.
28. Louwman WJ, Janssen-Heijnen ML, Houterman S, Voogd AC, van der Sangen MJ, Nieuwenhuijzen GA, et al., Less extensive treatment and inferior prognosis for breast cancer patient with comorbidity: a population-based study. Eur J Cancer 2005; 41: 779-785.